HomeBWAY • NASDAQ
add
Brainsway ADR Representing 2 Ord Shs
Previous close
$5.40
Day range
$5.35 - $5.50
Year range
$1.49 - $7.62
Market cap
335.17M ILS
Avg Volume
62.49K
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 9.10M | 37.28% |
Operating expense | 6.72M | -20.95% |
Net income | 111.00K | 104.57% |
Net profit margin | 1.22 | 103.33% |
Earnings per share | — | — |
EBITDA | 410.00K | 112.27% |
Effective tax rate | 60.78% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.58M | 7.35% |
Total assets | 65.14M | 5.15% |
Total liabilities | 23.15M | 21.58% |
Total equity | 42.00M | — |
Shares outstanding | — | — |
Price to book | 4.29 | — |
Return on assets | 0.36% | — |
Return on capital | 0.55% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | 111.00K | 104.57% |
Cash from operations | 3.18M | 189.75% |
Cash from investing | -710.00K | -1,209.38% |
Cash from financing | -589.00K | -792.42% |
Net change in cash | 1.86M | 152.75% |
Free cash flow | 2.34M | 199.78% |
About
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
CEO
Founded
2003
Headquarters
Website
Employees
134
